Charles River Laboratories CRL Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $4.03B+0.3% | $4.02B-0.2% | $4.02B-0.1% | $4.03B+0.1% | $4.02B-0.7% | ||
| $724.7M-2.5% | $743.07M+0.1% | $742.65M-2.8% | $764.27M+2.9% | $742.51M-1.1% | ||
| —— | —— | —— | —— | —— | ||
| $105.89M-1.1% | $107.03M-4.0% | $111.49M-4.2% | $116.37M-2.4% | $119.17M-5.6% | ||
| —— | —— | -$57.38M-78.4% | -$32.17M+6.9% | -$34.56M-109% | ||
| —— | —— | $60.47M+21.5% | $49.77M-11.8% | $56.44M-20.4% | ||
| -$184.65M-27.9% | -$144.34M— | —— | —— | —— | ||
| -4.6%-1.0pp | -3.6%— | —— | —— | —— | ||
| -$3.70-27.6% | -$2.90— | —— | —— | —— | ||
| $702.83M-1.1% | $710.81M-9.7% | $787.25M+1.7% | $773.89M-2.3% | $791.99M-2.0% | ||
| 17.5%-0.2pp | 17.7%-1.9pp | 19.6%+0.4pp | 19.2%-0.5pp | 19.7%-0.3pp | ||
| $352.73M+14.7% | $307.5M-14.6% | $360.11M+4.8% | $343.72M-13.0% | $395.24M-11.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Charles River Laboratories's revenue?
- Charles River Laboratories (CRL) generated $4.0B in revenue over the trailing twelve months, up 0.1% year over year.
- Is Charles River Laboratories profitable?
- Charles River Laboratories is not currently profitable: it reported a net loss of $184.7M over the trailing twelve months, a -4.6% net margin.
- What are Charles River Laboratories's profit margins?
- Gross margin is 84.7% and operating margin is 13.0%, with a -4.6% net margin.
- What is Charles River Laboratories's earnings per share?
- Charles River Laboratories's diluted EPS over the trailing twelve months is $-3.70.
- Where does Charles River Laboratories's income statement data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
